US Patent Issued to Amerimmune on Aug. 5 for "Treatment for diseases caused by RNA virus SARS-CoV-2" (Virginia Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,127, issued on Aug. 5, was assigned to Amerimmune LLC (Fairfax, Va.).

"Treatment for diseases caused by RNA virus SARS-CoV-2" was invented by Oral Alpan (Fairfax, Va.) and Matthew Plassmeyer (Fairfax, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Up-regulation of caspase has been found in COVID-19 patients, and also occurs in patients suffering from diabetes, hypertension, metabolic syndrome, and other conditions. Such up-regulation can be responsible for poor clinical outcomes in patients having such diseases or disorders, as such up-regulation leads to a process called pyroptosis: death and malfunction of immune system cells, particularly of c...